Ebru Demirci, Grace Omes‐Smit, & Alex Zwiers. (2023). Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU. Wiley.
Chicago Style (17th ed.) CitationEbru Demirci, Grace Omes‐Smit, and Alex Zwiers. Clinical Development Time Is Shorter for New Anticancer Drugs Approved via Accelerated Approval in the US or via Conditional Approval in the EU. Wiley, 2023.
MLA (9th ed.) CitationEbru Demirci, et al. Clinical Development Time Is Shorter for New Anticancer Drugs Approved via Accelerated Approval in the US or via Conditional Approval in the EU. Wiley, 2023.
Warning: These citations may not always be 100% accurate.